The ability of ozone to modulate the Nrf2/Keap1/ARE system and the NO/eNOS signaling pathways may provide insightful suggestions to highlight possible mechanisms underlying the effect of O2-O3-AHT in ME/CFS-caused fatigue symptomatology [27]. The gene discussed is KEAP1; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.